Korea Herald – BusinessMarkets
SK Bioscience joins $99m BDBV vaccine development project
SK Bioscience said Thursday it will join a Bundibugyo virus vaccine development project backed by up to $99 million from the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority. The initiative, involving nonprofit research…